RETRACTED ARTICLE: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer

References

Page 1

	Year	Citations
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method Ting‐Chao Chou Cancer Research	2010	5.5K
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Balázs Győrffy, András Lánczky, Aron C. Eklund, Breast Cancer Research and Treatment Breast OncologyMedicineCancer GenomicsCancer RegistrationBreast Cancer	2009	4.3K
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Jennet Harvey, Gary M. Clark, C. Kent Osborne, Journal of Clinical Oncology	1999	2.1K
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α Robert A. Campbell, Poornima Bhat‐Nakshatri, Nikhil Patel, Journal of Biological Chemistry Estrogen ReceptorsMolecular PhysiologySignal TransductionPromoter RegionSignaling Pathway	2001	947
HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium Elena N. Pugacheva, Sandra A. Jablonski, Tiffiney R. Hartman, Cell Signal TransductionNatural SciencesCell InteractionMolecular BiologyPrimary Cilium	2007	878
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol Shubha Anand, Sue Penrhyn-Lowe, Ashok R. Venkitaraman Cancer Cell Cell DivisionNatural SciencesMagnetic ResonanceDna ReplicationMolecular Biology	2003	641
Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215 Qiyuan Liu, Satoshi Kaneko, Lin Yang, Journal of Biological Chemistry Molecular RegulationApoptosisMolecular BiologyCell DeathTumor Biology	2004	345
pp90<sup>rsk1</sup> Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 Peteranne B. Joel, Jeffrey A. Smith, Thomas W. Sturgill, Molecular and Cellular Biology	1998	343
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. S R Johnston, Gloria Saccani‐Jotti, I. E. Smith, PubMed Tumor BiologyBreast OncologyProgesterone ReceptorTamoxifen ResistanceMedicine	1995	304
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays Mark Manfredi, Jeffrey Ecsedy, Arijit Chakravarty, Clinical Cancer Research	2011	298

Page 1